Related Tags >> Genentech Roche FDA Rituxan

Herceptin News

Most Popular Herceptin Story

MAbs are hottest segment of biotech industry

October 12, 2007 — 6:59am ET

Looking for the hottest segment of the biotech industry? Then take a look at monoclonal antibodies (mAbs). A new Datamonitor report projects 14 percent annual growth in the market for the antibody... Read more...

Herceptin Press Releases

Herceptin now shown to significantly prolong the lives of patients with HER2-positive advanced stomach cancer
Ipsogen Launches a New Test to Determine Tumor HER2 Status and Guide Herceptin(R) Prescription in Breast Cancer
PRESS RELEASE: Herceptin eradicates tumours and may reduce the need for mastectomies in women

Latest Headlines

Invitrogen gets breast cancer test approval
July 9, 2008
SPOTLIGHT: Pertuzumab slows breast cancer in study
May 30, 2008
Daiichi snares Germany's U3 in $235M acquisition
May 21, 2008
MAbs are hottest segment of biotech industry
October 12, 2007
ALSO NOTED: FDA approves antibody; Nastech to raise $42M; MGI publishes data; and much more...
January 17, 2007
Genentech hiring researchers in big R&D push
January 9, 2007
ALSO NOTED: Semaphore closes $9.5M round; VaxGen looks to refocus; BioCryst wins $102M contract; and much more...
January 4, 2007
ALSO NOTED: Europe expands Synvisc approval; FDA issues "approvable" letter for paliperidone; and much more...
October 1, 2006
SPOTLIGHT: JCO warns on radiation, Herceptin
August 14, 2006
ALSO NOTED: Biogen says safety first, efficacy second; Roche chief unconcerned by Tykerb; and much more...
June 19, 2006
ALSO NOTED: Aphton files for bankruptcy; Akorn wins FDA OK; and much more...
May 23, 2006
ALSO NOTED: Study finds for-profit bias; TorreyPines gets positive data in Phase I; and much more...
May 16, 2006
ALSO NOTED: PerkinElmer buys Spectral Genomics; Europe OKs early use of Herceptin; and much more...
May 1, 2006
ALSO NOTED: Bayer ups Schering bid; Antibiotic may work against serious asthma attack; and much more...
April 12, 2006
Roche files for expanded use of Herceptin
February 16, 2006
Genentech wears crown in drug development
December 22, 2005
ALSO NOTED: Hana BioSciences raises $14.7M;CepTor wins $1.5M milestone; Herceptin wins raves; and much more...
October 19, 2005
ALSO NOTED: Genaera touts Phase II results; Genentech reports big increase in profits; Predicant lines up debt financing; and m
October 10, 2005
ALSO NOTED: Adams Respiratory sets IPO price; Parexel buys QdotPharma; Amrad gains patent; BioAlliance prepares for Phase III;
July 20, 2005
C&L: North tapped to run Inimex
June 7, 2005

Paid Research Reports

More Research Reports >>